COVID-19 Medication Therapy

CHF 47.55
Auf Lager
SKU
4LUI9FLBDLS
Stock 1 Verfügbar
Geliefert zwischen Mo., 22.12.2025 und Di., 23.12.2025

Details

This book will provide information on the use of COVID-19 drugs and outlines the vaccination and drug treatment options for COVID-19 infection. Many viral infectious diseases have afflicted the world in the last 10 to 15 years. Its spread has a massive impact on the global economy and public health system. The outbreak of an unidentified pneumonia caused by the new strain SARS CoV-2 was identified and reported to the Chinese Health Commission in Wuhan (Hubei Province, China). Because of the SARS CoV-2's ability to spread and infect people at a higher rate around the world, thousands of antiviral drugs have been developed and are being used as antivirals. They cannot, however, work out a complete cure. As a result, the world began to initiate vaccine development. In this review we discussed the virology and pathophysiology of SARS CoV-2, as well as current therapeutic approaches to the disease. Some vaccines have been developed and are currently being used to prevent COVID-19 infection.

Autorentext

Karthikeyan Elumalai concluiu a licenciatura em Farmácia e o mestrado em Farmácia na Tamilnadu Dr. MGR. Medical University, Chennai, e doutoramento pela Sunrise University.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09786203847536
    • Sprache Englisch
    • Größe H220mm x B150mm x T5mm
    • Jahr 2021
    • EAN 9786203847536
    • Format Kartonierter Einband
    • ISBN 6203847534
    • Veröffentlichung 15.04.2021
    • Titel COVID-19 Medication Therapy
    • Autor Karthikeyan Elumalai , Arulmani Saravanan , Abinash Baskaran
    • Gewicht 119g
    • Herausgeber LAP LAMBERT Academic Publishing
    • Anzahl Seiten 68
    • Genre Medical Books

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470